DIMENSIONAL FUND ADVISORS LP - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 162 filers reported holding CARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$424,233
-62.8%
252,499
-37.4%
0.00%
Q2 2023$1,140,672
-75.4%
403,040
-57.4%
0.00%
-100.0%
Q1 2023$4,644,212
+42429.4%
945,882
-7.0%
0.00%
-33.3%
Q4 2022$10,920
-99.9%
1,016,760
+0.2%
0.00%
-25.0%
Q3 2022$9,496,000
-0.4%
1,014,562
-2.8%
0.00%
+33.3%
Q2 2022$9,534,000
-0.9%
1,044,101
+31.8%
0.00%0.0%
Q1 2022$9,625,000
+48.7%
792,191
+49.1%
0.00%
+50.0%
Q4 2021$6,472,000
+18.3%
531,350
+50.1%
0.00%0.0%
Q3 2021$5,470,000
-8.9%
354,085
-15.8%
0.00%0.0%
Q2 2021$6,003,000
+337.2%
420,671
+563.8%
0.00%
Q1 2021$1,373,000
+31.9%
63,369
-7.8%
0.00%
Q4 2020$1,041,000
+22.0%
68,753
+2.5%
0.00%
Q3 2020$853,000
-25.2%
67,046
+0.6%
0.00%
-100.0%
Q2 2020$1,140,000
+152.2%
66,678
+94.8%
0.00%
Q1 2020$452,000
-18.1%
34,2350.0%0.00%
Q4 2019$552,000
+111.5%
34,235
+62.4%
0.00%
Q1 2018$261,000
+1.2%
21,0840.0%0.00%
Q4 2017$258,000
-10.7%
21,0840.0%0.00%
Q3 2017$289,000
-90.9%
21,084
-89.8%
0.00%
-100.0%
Q2 2017$3,182,000
-16.8%
206,754
-0.6%
0.00%
-50.0%
Q1 2017$3,824,000
+79.3%
207,950
-9.4%
0.00%
+100.0%
Q4 2016$2,133,000
+52.9%
229,626
+37.4%
0.00%0.0%
Q3 2016$1,395,000167,1080.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,204,449$10,8241.35%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,233,000$6,054,0301.14%
Chescapmanager LLC 1,160,392$5,6980.90%
DISCIPLINED GROWTH INVESTORS INC /MN 1,732,375$8,505,9610.22%
XTX Topco Ltd 107,610$528,3650.11%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$415,0420.08%
PINNACLE ASSOCIATES LTD 679,413$3,335,9180.07%
PDT Partners, LLC 102,010$500,8690.07%
FARALLON CAPITAL MANAGEMENT LLC 1,995,370$9,797,2670.05%
AXQ CAPITAL, LP 27,760$136,3020.05%
View complete list of CARA THERAPEUTICS INC shareholders